You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rheumatoid arthritis with inadequate response to 1 anti-TNF

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prospective, Multi-Center, Observational, Whole Blood Specimen

Not yet recruiting
  • Rheumatoid Arthritis
    • (no location specified)
    Jun 30, 2023

    Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Aug 25, 2023

    Rheumatoid Arthritis Trial in Montpellier (Blood sampling)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Blood sampling
    • Montpellier, France
      Centre Hospitalier Universitaire de Montpellier
    Mar 24, 2023

    Rheumatoid Arthritis Trial (ABT-494, Placebo)

    Completed
    Has Results
    • Rheumatoid Arthritis
    • (no location specified)
    Jul 29, 2021

    Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

    Completed
    • Rheumatoid Arthritis
    • LNK01001 Dose A
    • +2 more
    • Beijing, China
      Peking Union Medical College Hospital
    Oct 24, 2023

    Rheumatoid Arthritis Trial in Chi?inau (AP1189, 60 mg, AP1189, 80 mg, AP1189, 100 mg)

    Recruiting
    • Rheumatoid Arthritis
    • AP1189, 60 mg
    • +3 more
    • Chișinău, Moldova, Republic of
      Timofei Mosneaga Republican Clinical Hospital
    Jan 5, 2023

    Rheumatoid Arthritis Trial in Italy (Tocilizumab, Etanercept, Infliximab)

    Recruiting
    • Rheumatoid Arthritis
    • Bari, Italy
    • +21 more
    Nov 12, 2020

    Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

    Recruiting
    • Rheumatoid Arthritis
    • +2 more
    • Infliximab: Adalimumab; Etanercept;
    • Sulaymaniyah, Kurdistan Region, Iraq
      Hiwa Khidhir Saaed
    May 12, 2022

    Rheumatoid Arthritis Trial in Abu Dhabi (Anti-TNF, JAK inhibitor)

    Not yet recruiting
    • Rheumatoid Arthritis
    • Abu Dhabi, United Arab Emirates
      Abu Dhabi Stem Cells Center
    May 17, 2022

    Rheumatoid Arthritis Trial (HLX01)

    Completed
    • Rheumatoid Arthritis
    • (no location specified)
    May 4, 2022

    Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

    Recruiting
    • Rheumatoid Arthritis
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 7, 2022

    Rheumatoid Arthritis Trial in Le Kremlin-Bicêtre (sms and emails reminders, No reminders)

    Completed
    • Rheumatoid Arthritis
    • sms and emails reminders
    • No reminders
    • Le Kremlin-Bicêtre, France
      Hôpital Bicêtre
    Oct 25, 2022

    Rheumatoid Arthritis Trial (GS-5718, Placebo to match GS-5718, Tofacitinib 5 mg)

    Withdrawn
    • Rheumatoid Arthritis
    • (no location specified)
    May 11, 2022

    Moderately to Severely Active Rheumatoid Arthritis Trial in Jiujiang (HLX01, Methotrexate(MTX))

    Completed
    • Moderately to Severely Active Rheumatoid Arthritis
    • Jiujiang, Jiangxi, China
      Jiujiang No.1 peoples's hospital
    May 4, 2022

    Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment

    Recruiting
    • Arthritis, Rheumatoid
    • +2 more
      • Aalborg, Denmark
        Department of rheumatology
      Sep 1, 2022

      Rheumatoid Arthritis Trial (Brodalumab, Placebo, Methotrexate)

      Completed
      Has Results
      • Rheumatoid Arthritis
      • (no location specified)
      Nov 22, 2021

      Rheumatoid Arthritis Trial in La Jolla (Diet 1, Diet 2)

      Recruiting
      • Rheumatoid Arthritis
      • Diet 1
      • Diet 2
      • La Jolla, California
        UCSD
      Jul 19, 2022

      Rheumatoid Arthritis Trial in China (Tocilizumab, MTX, Placebo Matched to MTX)

      Completed
      • Rheumatoid Arthritis
      • Baotou, China
      • +19 more
      Dec 5, 2022

      Rheumatoid Arthritis, JAK Inhibitor, IL-6 Inhibitor Trial in Nagasaki (filgotinib 200mg/day, subcutaneous tocilizumab

      Recruiting
      • Rheumatoid Arthritis
      • +4 more
      • filgotinib 200mg/day
      • subcutaneous tocilizumab 162mg/biweekly
      • Nagasaki, Japan
        Nagasaki University Hospital
      Oct 23, 2021

      Rheumatoid Arthritis (RA) Trial in China, Korea, Republic of, Taiwan (Peficitinib, Plaebo, Disease-modifying antirheumatic drugs

      Completed
      • Rheumatoid Arthritis (RA)
      • Anhui, China
      • +42 more
      Jan 7, 2023

      Arthritis, Psoriatic Trial in Worldwide (Guselkumab 100 mg, Placebo)

      Completed
      • Arthritis, Psoriatic
      • Guselkumab 100 mg
      • Placebo
      • Brussels, Belgium
      • +116 more
      Nov 29, 2021

      Rheumatoid Arthritis Trial in Worldwide (ABX464 50mg, Matching Placebo, ABX464 100mg)

      Completed
      Has Results
      • Rheumatoid Arthritis
      • ABX464 50mg
      • +3 more
      • Bruxelles, Belgium
      • +23 more
      Feb 3, 2022

      Anti-citrullinated Protein Antibody Status on Treatment Response

      Completed
      • Rheumatoid Arthritis
      • Non-Interventional
      • Canberra City, Australia
        (unnamed)
      Feb 22, 2022

      Rheumatoid Arthritis Trial (MBS2320 5 mg, MBS2320 20 mg, MBS2320 40 mg)

      Not yet recruiting
      • Rheumatoid Arthritis
      • MBS2320 5 mg
      • +3 more
      • (no location specified)
      Jul 12, 2022

      Rheumatoid Arthritis Trial in Beijing (BAT1806, Actemra(EU-licensed))

      Completed
      • Rheumatoid Arthritis
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Nov 16, 2021